Showing 4781-4790 of 5771 results for "".
- Immediate Surgery Combined with Injections for Submacular Bleeding May be Most Effective for Restoring Visionhttps://modernod.com/news/immediate-surgery-combined-with-injections-for-submacular-bleeding-may-be-most-effective-for-restoring-vision/2477499/The Mount Sinai Health System in New York announced the publication of a paper titled “Outcomes of pars plana vitrectomy with subretinal tissue plasminogen activator injection and pneumatic displacement of fovea-involving submacular haemorrhage” in the British Journal of Ophthalmology.</
- CMS to Make Expedited Advance Payments to Medicare Providershttps://modernod.com/news/cms-will-make-expedited-advance-payments-to-medicare-providers/2477498/The Centers for Medicare & Medicaid Services (CMS) has announced an expansion of its accelerated and advance payment program for Medicare-participating health care providers and suppliers. This program expansion, which comes from the recently enacted Coronavirus Aid, Relief, and Econom
- Eyevance Pharmaceuticals Launches Zerviate in the United Stateshttps://modernod.com/news/eyevance-pharmaceuticals-launches-zerviate-in-the-united-states/2477486/Eyevance Pharmaceuticals has announced the United States launch of Zerviate (cetirizine ophthalmic solution) 0.24% for the treatment of ocular itching associated with allergic conjunctivitis. Zerviate is formulated with Hydrella, the vehicle that contains glycerin and hydroxypropyl methylcellulos
- The Allergan Foundation Donates $2 Million to Community Organizations on Front Line of COVID-19 Responsehttps://modernod.com/news/the-allergan-foundation-donates-2-million-to-community-organizations-on-front-line-of-covid-19-response/2477485/Allergan announced that The Allergan Foundation has awarded approximately $13 million in charitable grants in 2020. The 2020 donations support programs dedicated to the COVID-19 pandemic response, as well as initiatives supporting mental health, eye care, and breast
- Responding to COVID-19, National Vision and Warby Parker Extend Store Closures, National Vision Moves to Trim Expenseshttps://modernod.com/news/responding-to-covid-19-national-vision-and-warby-parker-extend-store-closures-national-vision-moves-to-trim-expenses/2477481/Two leading optical retailers announced late last week that they are extending the time period in which their stores will be closed due to the coronavirus outbreak, according to a VisionMonday
- Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minuteshttps://modernod.com/news/abbott-launches-molecular-point-of-care-test-to-detect-novel-coronavirus-in-as-little-as-five-minutes/2477479/Abbott announced that the FDA has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as 5 minutes and negative results in 13 minutes, according to a company new
- Sun Pharmaceutical Donates 2.5 Million Hydroxychloroquine Sulfate Tablets in the US For Potential COVID-19 Treatmenthttps://modernod.com/news/sun-pharmaceutical-donates-2-5-million-hydroxychloroquine-sulfate-tablets-in-the-us-for-potential-covid-19-treatment/2477480/Sun Pharmaceutical Industries announced that it has donated 2.5 million hydroxychloroquine sulfate tablets for use in the United States. Sun Pharma is seeking to enable health care experts meet the growing patient demands for this product as they assess its potential to treat COVID-19 through cli
- Aldeyra to Screen Clinical-Stage Compounds for Activity in COVID-19 Infectionhttps://modernod.com/news/aldeyra-to-screen-clinical-stage-compounds-for-activity-in-covid-19-infection/2477461/Aldeyra Therapeutics announced that it will begin screening its library of novel reactive aldehyde species (RASP) inhibitors, including ADX-629 and reproxalap, for potential anti-inflammatory and antiviral activity in the treatment of COVID-19 infection. ADX-629 and reproxalap are structur
- Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patientshttps://modernod.com/news/results-from-first-clinical-study-using-danoprevir-to-treat-naive-and-experienced-covid-19-patients/2477455/Ascletis Pharma announced the first clinical study using Ganovo (danoprevir) to treat naive and experienced COVID-19 patients was published in medRxiv. The data from this small-sample clinical study showed that danoprevir combined with ritonavir is safe and well tolerated in all p
- Iveric Bio Appoints Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officerhttps://modernod.com/news/iveric-bio-appoints-pravin-u-dugel-md-as-executive-vice-president-and-chief-strategy-and-business-officer/2477448/Iveric bio announced the appointment of Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer, effective April 1, 2020. In this role, Dr. Dugel will help shape Iveric bio’s business development strategy going forward. Dr. Dugel brings more than 25 years’ experie